Smoking cessation and risk of type 2 diabetes
Authors:
Jana Malinovská 1,2; Jana Urbanová 3; Veronika Vejtasová 4; Alexandra Romanová 1; Sabina Pálová 1; Syed Taha Naeem 1; Jan Brož 1
Authors place of work:
Interní klinika 2. LF UK a FN Motol, Praha
1; Adiktologická poradna, odborné pracoviště Area fausta, Praha
2; Interní klinika 3. LF UK a FN KV, Praha
3; Kardiologická klinika 2. LF UK a FN Motol, Praha
4
Published in the journal:
Vnitř Lék 2022; 68(E-1): 4-8
Category:
Přehledové články
Summary
Risk of type 2 diabetes mellitus (T2DM) is higher in tobacco smokers compared to non-smokers. The risk declines after smoking cessation. However, ex-smokers are also more prone to the metabolic syndrome. The question thus is, whether ex-smokers could temporarily have a higher risk of T2DM than current smokers. The available studies on this topic are not in agreement in their conclusions, as most of them also primarily do not compare ex-smokers to current smokers, but to non-smokers. However, based on the available studies, it rather seems the risk of T2DM is temporarily higher after smoking cessation. The higher risk of T2DM seems to be enhanced by weight gain that typically occurs first years after smoking cessation without intervention. Therefore, smoking cessation in patients who are in an increased risk of T2DM should be accompanied by T2DM preventative measures (lifestyle modification, weight monitoring and recommendation of pharmacotherapy of tobacco addiction to lower the risk of weight gain) and more frequent checks of blood glucose level to ensure early T2DM detection.
Keywords:
smoking – type 2 diabetes mellitus – risk factors – smoking cessation
Zdroje
1. Willi C, Bodenmann P, Ghali WA et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta‑analysis. JAMA 2007;298:2654-2664. doi: 10.1001/ jama.298. 22. 2654.
2. Śliwińska‑Mossoń M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diab Vasc Dis Res 2017;14:265–276. doi: 10.1177/1479164117701876.
3. Harris KK, Zopey M, Friedman TC. Metabolic effects of smoking cessation [published correction appears in Nat Rev Endocrinol. 2016 Nov;12 (11):684]. Nat Rev Endocrinol 2016; 12:299-308. doi:10.1038/nrendo.2016.32
4. Matsushita Y, Nakagawa T, Yamamoto S et al. Associations of Smoking Cessation With Visceral Fat Area and Prevalence of Metabolic Syndrome in Men: The Hitachi Health Study. Obesity 2011;19:647-651. https://doi.org/10.1038/oby.2010.237
5. Csémy L, Dvořáková Z, Fialová A et al. Užívání tabáku a alkoholu v České republice 2019, Výzkumná zpráva. Praha: SZÚ 2020. ISBN 978-80-7071-394-5
6. Brož J, Malinovská J, Nunes MA et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25-64 in the Czech Republic: A cross‑sectional study. Diabetes Res Clin Pract 2020;170:108470. doi: 10.1016/j.diabres.2020.108470.
7. Clair C, Meigs JB, Rigotti NA. Smoking behavior among US adults with diabetes or impaired fasting glucose. Am J Med 2013;126:541.e15-e8. doi: 10.1016/j.amjmed.2012. 11. 029.
8. Alshahrani A. The Effects of Smoking Cessation on Diabetes Mellitus Patients. Curr Diabetes Rev 2020;16(2):137–142. doi: 10.2174/1573399815666190729111041. PMID: 31362677.
9. Aubin H, Farley A, Lycett D et al. Weight gain in smokers after quitting cigarettes: meta‑analysis BMJ 2012;345:e4439 doi:10.1136/bmj.e4439.
10. Hu Y, Zong G, Liu G et al. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality. N Engl J Med 2018;379:623-632. doi: 10.1056/NEJMoa1803626.
11. Stein JH, Asthana A, Smith SS et al. Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three‑year outcomes after a quit attempt. PLoS One 2014; 9: e98278. doi: 10.1371/journal.pone.0098278.
12. Yeh HC, Duncan BB, Schmidt MI et al. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 2010;152:10-7. doi: 10.7326/0003-4819- 152-1-201001050-00005.
13. Sung YT, Hsiao CT, Chang IJ et al. Smoking Cessation Carries a Short‑Term Rising Risk for Newly Diagnosed Diabetes Mellitus Independently of Weight Gain: A 6-Year Retrospective Cohort Study. J Diabetes Res 2016;2016:3961756. doi: 10.1155/2016/3961756.
14. Hur NW, Kim HC, Nam CM et al. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil 2007;14:244-249. doi: 10.1097/01.hjr.0000239474.41379. 79.
15. Wannamethee SG, Shaper AG, Perry IJ; British Regional Heart Study. Smoking as a modifiable risk factor for type 2 diabetes in middle‑aged men. Diabetes Care 2001;24:1590- 1595. doi: 10.2337/diacare.24. 9. 1590.
16. Luo J, Rossouw J, Tong E et al. Smoking cessation, weight gain, and risk of type 2 diabetes mellitus among postmenopausal women. Arch Intern Med 2012;172:438-440. doi: 10.1001/archinternmed.2012. 24.
17. Pan A, Wang Y, Talaei M et al. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta‑analysis. Lancet Diabetes Endocrinol 2015;3:958-967. doi: 10.1016/S2213-8587(15)00316-2.
18. Park SE, Seo MH, Cho JH et al. Dose‑Dependent Effect of Smoking on Risk of Diabetes Remains after Smoking Cessation: A Nationwide Population‑Based Cohort Study in Korea. Diabetes Metab J 2021;45:539-546. doi: 10.4093/dmj.2020.0061.
19. Choi JW, Kim TH, Han E. Smoking Cessation, Weight Change, Diabetes, and Hypertension in Korean Adults. Am J Prev Med 2021;60:205-212. doi: 10.1016/j.amepre.2020. 08. 024.
20. Akter S, Goto A, Mizoue T. Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta‑analysis. J Epidemiog 2017;27:553-561. doi: 10.1016/j.je.2016. 12. 017.
21. Clair C, Rigotti NA, Porneala B, Fox CS, D‘Agostino RB, Pencina MJ, Meigs JB. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 2013 Mar 13;309(10):1014-1021. doi: 10.1001/jama.2013.1644.
22. American Diabetes Association Professional Practice Committee; 5. Facilitating Behavior Change and Well‑being to Improve Health Outcomes: Standards of Medical Care in Diabetes–2022. Diabetes Care 2022; 45 (Supplement_1): S60-S82. https://doi.org/10.2337/ dc22-S005
23. Králíková E, Češka R, Pánková A et al. Doporučení pro léčbu závislosti na tabáku. Vnitr Lek 2015;61(Supplementum 1):3-15.
24. Li WH, Wang MP, Lam TH, Cheung YT, Cheung DY, Suen YN, Ho KY, Tan KC, Chan SS. Brief intervention to promote smoking cessation and improve glycemic control in smokers with type 2 diabetes: a randomized controlled trial. Sci Rep 2017;7:45902. doi: 10.1038/srep45902.
25. Bush T, Lovejoy JC, Deprey M et al. The effect of tobacco cessation on weight gain, obesity, and diabetes risk. Obesity 2016;24:1834-1841. doi: 10.1002/oby.21582.
Štítky
Diabetologie Endokrinologie Interní lékařstvíČlánek vyšel v časopise
Vnitřní lékařství
2022 Číslo E-1
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Pregabalin je účinné léčivo s příznivým bezpečnostním profilem pro pacienty s neuropatickou bolestí
- Vhodná dávka levothyroxinu u obézních pacientů s hypothyreózou
- Nedostatek hořčíku se projevuje u stále více lidí
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
Nejčtenější v tomto čísle
- Možnosti cvičenia v liečbe ankylozujúcej spondylitídy
- Vyšetření renální funkce v praxi
- Zanechání kouření a riziko diabetes mellitus 2. typu
- Závažné zlyhávanie srdca a arytmia po protinádorovej liečbe podávanej v detstve
Zvyšte si kvalifikaci online z pohodlí domova
Kardiologické projevy hypereozinofilií
nový kurzVšechny kurzy